M. AKÇAY (CİBLAK), "Evaluation of amphotericin B interpretive breakpoints for Candida bloodstream isolates by correlation with therapeutic outcome," ANTIMICROBIAL AGENTS AND CHEMOTHERAPY , vol.50, no.4, pp.1287-1292, 2006
AKÇAY (CİBLAK), M. 2006. Evaluation of amphotericin B interpretive breakpoints for Candida bloodstream isolates by correlation with therapeutic outcome. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY , vol.50, no.4 , 1287-1292.
AKÇAY (CİBLAK), M., (2006). Evaluation of amphotericin B interpretive breakpoints for Candida bloodstream isolates by correlation with therapeutic outcome. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY , vol.50, no.4, 1287-1292.
AKÇAY (CİBLAK), Meral. "Evaluation of amphotericin B interpretive breakpoints for Candida bloodstream isolates by correlation with therapeutic outcome," ANTIMICROBIAL AGENTS AND CHEMOTHERAPY , vol.50, no.4, 1287-1292, 2006
AKÇAY (CİBLAK), Meral. "Evaluation of amphotericin B interpretive breakpoints for Candida bloodstream isolates by correlation with therapeutic outcome." ANTIMICROBIAL AGENTS AND CHEMOTHERAPY , vol.50, no.4, pp.1287-1292, 2006
AKÇAY (CİBLAK), M. (2006) . "Evaluation of amphotericin B interpretive breakpoints for Candida bloodstream isolates by correlation with therapeutic outcome." ANTIMICROBIAL AGENTS AND CHEMOTHERAPY , vol.50, no.4, pp.1287-1292.
@article{article, author={Meral AKÇAY}, title={Evaluation of amphotericin B interpretive breakpoints for Candida bloodstream isolates by correlation with therapeutic outcome}, journal={ANTIMICROBIAL AGENTS AND CHEMOTHERAPY}, year=2006, pages={1287-1292} }